(Q3)Mar 31, 2024 | (Q2)Dec 31, 2023 | (Q1)Sep 30, 2023 | (FY)Jun 30, 2023 | (Q4)Jun 30, 2023 | (Q3)Mar 31, 2023 | (Q2)Dec 31, 2022 | (Q1)Sep 30, 2022 | (FY)Jun 30, 2022 | (Q4)Jun 30, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow (Indirect Method) | ||||||||||
Cash flow from continuing operating activities | 24.97%-126.42K | 6.95%-172.7K | 75.15%-66.34K | 48.37%-899.52K | 43.37%-278.47K | 76.43%-168.49K | 38.73%-185.6K | -14.78%-266.96K | -57.98%-1.74M | -102.78%-491.7K |
Net income from continuing operations | 46.57%-96.41K | 46.71%-131.27K | 41.18%-115.07K | -23.89%-2.96M | -101.73%-2.34M | 74.83%-180.45K | 16.27%-246.32K | 10.52%-195.63K | 4.90%-2.39M | -152.97%-1.16M |
Asset impairment expenditure | ---- | ---- | ---- | --2.12M | ---- | ---- | ---- | ---- | ---- | ---- |
Remuneration paid in stock | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- | -55.06%615.33K | ---- |
Change In working capital | -350.94%-30.01K | -168.22%-41.43K | 168.32%48.73K | -312.56%-64.22K | -228.90%-65.57K | 492.32%11.96K | 794.75%60.72K | -411.86%-71.33K | -22.40%30.21K | 449.38%50.87K |
-Change in receivables | 42.61%-3.39K | -104.15%-2.98K | -143.93%-2.41K | 262.10%70.22K | 95.12%-1.07K | 43.61%-5.91K | 1,143.67%71.72K | 232.64%5.47K | -49.03%-43.32K | -265.43%-21.84K |
-Change in prepaid assets | ---- | ---- | --14.19K | -169.44%-14.19K | -525.68%-14.19K | ---- | ---- | --0 | 298.09%20.43K | 125.35%3.33K |
-Change in payables and accrued expense | -193.01%-16.62K | -120.55%-24.26K | 148.11%36.95K | -326.46%-120.25K | -172.52%-50.31K | 133.08%17.87K | -56.34%-11K | -354.23%-76.8K | -32.20%53.1K | 144.44%69.38K |
Cash from discontinued investing activities | ||||||||||
Operating cash flow | 24.97%-126.42K | 6.95%-172.7K | 75.15%-66.34K | 48.37%-899.52K | 43.37%-278.47K | 76.43%-168.49K | 38.73%-185.6K | -14.78%-266.96K | -57.98%-1.74M | -102.78%-491.7K |
Investing cash flow | ||||||||||
Cash flow from continuing investing activities | 0 | 0 | -234.27K | -162.88K | -1 | -162.88K | 0 | 0 | 0 | 0 |
Net PPE purchase and sale | --0 | --0 | ---234.27K | ---162.88K | ---1 | ---162.88K | --0 | --0 | --0 | --0 |
Cash from discontinued investing activities | ||||||||||
Investing cash flow | --0 | --0 | ---234.27K | ---162.88K | ---1 | ---162.88K | --0 | --0 | --0 | --0 |
Financing cash flow | ||||||||||
Cash flow from continuing financing activities | 0 | 30.59%3.66M | 21.86K | |||||||
Net common stock issuance | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- | 36.41%3.96M | 221.36%321.52K |
Proceeds from stock option exercised by employees | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- | --20K | ---- |
Net other financing activities | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -219.50%-319.66K | ---- |
Cash from discontinued financing activities | ||||||||||
Financing cash flow | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- | 30.59%3.66M | --21.86K |
Net cash flow | ||||||||||
Beginning cash position | -33.06%2.19M | -31.66%2.37M | -28.49%2.67M | 105.47%3.73M | -29.86%2.95M | 156.10%3.28M | 118.80%3.46M | 105.47%3.73M | 1,179.59%1.81M | 101.72%4.2M |
Current changes in cash | 61.85%-126.42K | 6.95%-172.7K | -12.60%-300.6K | -155.50%-1.06M | 40.73%-278.47K | -111.35%-331.37K | 38.73%-185.6K | -14.78%-266.96K | 14.41%1.91M | -76.23%-469.84K |
End cash Position | -29.82%2.07M | -33.06%2.19M | -31.66%2.37M | -28.49%2.67M | -28.49%2.67M | -29.86%2.95M | 156.10%3.28M | 118.80%3.46M | 105.47%3.73M | 105.47%3.73M |
Free cash from | 61.85%-126.42K | 6.95%-172.7K | -12.60%-300.6K | 39.02%-1.06M | 43.37%-278.47K | 53.65%-331.37K | 38.73%-185.6K | -14.78%-266.96K | -54.51%-1.74M | -83.94%-491.7K |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
No Data